SAN FRANCISCO (June 15, 2018) – JUUL Labs today announced preliminary results from a study on harmful and potentially harmful constituents (HPHCs) in JUUL’s nicotine-filled pods. The findings, “HPHC Analysis of Eight Flavors of a Temperature-Regulated Nicotine Salt-Based ENDS Product,” were presented at a poster session at the Global Forum on Nicotine (GFN) 2018 in Warsaw, Poland.
The study, performed by an independent contract laboratory, examined HPHCs in aerosol generated from JUUL’s nicotine-filled pods consisting of eight different flavors. A panel of analytes, including HPHCs identified by the U.S. Food and Drug Administration (FDA), was measured and compared with combustible cigarettes. For all flavors, across 22 panel analytes measured, all analytes were below the level of quantification or detection.
“Clinical research builds the foundation of JUUL, and we remain steadfast in our commitment to share data with the scientific community,” said Gal Cohen, Senior Director of Scientific Affairs at JUUL Labs. “We are pleased to present the findings from one of our studies at the Global Forum on Nicotine to ensure that the scientific community can access factual information about our product.”
For more information on the data presented at GFN 2018, please view the abstract.
About JUUL Labs
JUUL Labs is a consumer product company dedicated to eliminating cigarettes by offering existing adult smokers a true alternative to combustible cigarettes. The company’s research shows more than one million smokers have already switched to JUUL, and we are working to enable millions more to switch in the coming years through technological innovations.
Media Contact: email@example.com